1.Shao K, Ding N, Huang S, Ren S, Zhang Y, Kuang Y, Guo Y, Ma H, An S, Li Y et al: Smart nanodevice combined tumor-
specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy.
ACS Nano 2014, 8(2):1191-1203.
2.Zhang C, Wan X, Zheng X, Shao X, Liu Q, Zhang Q, Qian Y: Dual-functional nanoparticles targeting amyloid plaqu
es in the brains of Alzheimer's disease mice. Biomaterials 2014, 35(1):456-465.
3.Zhang B, Zhang Y, Liao Z, Jiang T, Zhao J, Tuo Y, She X, Shen S, Chen J, Zhang Q et al: UPA-sensitive ACPP-conjuga
ted nanoparticles for multi-targeting therapy of brain glioma. Biomaterials 2015, 36:98-109.
4.Gao X, Qian J, Zheng S, Changyi Y, Zhang J, Ju S, Zhu J, Li C: Overcoming the blood-brain barrier for delivering dr
ugs into the brain by using adenosine receptor nanoagonist. ACS Nano 2014, 8(4):3678-3689.
5.Wang Y, Wang K, Zhang R, Liu X, Yan X, Wang J, Wagner E, Huang R: Synthesis of core-shell graphiticcarbon@sili
ca nanospheres with dual-ordered mesopores for cancer-targeted photothermochemotherapy.
ACS Nano 2014, 8(8):7870-7879.
6.Kan J, Guo W, Huang C, Bao G, Zhu Y, Zhu YZ: S-propargyl-cysteine, a novel water-soluble modulator of endoge
nous hydrogen sulfide, promotes angiogenesis through activation of signal transducer and activator of tra
nscription 3. Antioxid Redox Signal 2014, 20(15):2303-2316.
7.Yao H, Wang K, Wang Y, Wang S, Li J, Lou J, Ye L, Yan X, Lu W, Huang R: Enhanced blood-brain barrier penetration
and glioma therapy mediated by a new peptide modified gene delivery system. Biomaterials 2015, 37:345-352.
8.Han L, Liu M, Ye D, Zhang N, Lim E, Lu J, Jiang C: Tumor cell membrane-targeting pH-dependent electron donor-
acceptor fluorescence systems with low background signals. Biomaterials 2014, 35(9):2952-2960.
9.Gao H, Yang Z, Cao S, Xiong Y, Zhang S, Pang Z, Jiang X: Tumor cells and neovasculature dual targeting delivery
for glioblastoma treatment. Biomaterials 2014, 35(7):2374-2382.
10.Wang K, Zhang X, Liu Y, Liu C, Jiang B, Jiang Y: Tumor penetrability and anti-angiogenesis using iRGD-mediated
delivery of doxorubicin-polymer conjugates. Biomaterials 2014, 35(30):8735-8747.
11.Zhang X, Yao S, Liu C, Jiang Y: Tumor tropic delivery of doxorubicin-polymer conjugates using mesenchymal st
em cells for glioma therapy. Biomaterials 2015, 39:269-281.
12.Wang S, Li Y, Fan J, Wang Z, Zeng X, Sun Y, Song P, Ju D: The role of autophagy in the neurotoxicity of cationic
PAMAM dendrimers. Biomaterials 2014, 35(26):7588-7597.
13.Jiang X, Xin H, Ren Q, Gu J, Zhu L, Du F, Feng C, Xie Y, Sha X, Fang X: Nanoparticles of 2-deoxy-D-glucose functio
nalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma
treatment. Biomaterials 2014, 35(1):518-529.
14.Kang T, Gao X, Hu Q, Jiang D, Feng X, Zhang X, Song Q, Yao L, Huang M, Jiang X et al: iNGR-modified PEG-PLGA nan
oparticles that recognize tumor vasculature and penetrate gliomas. Biomaterials 2014, 35(14):4319-4332.
15.Gu G, Hu Q, Feng X, Gao X, Menglin J, Kang T, Jiang D, Song Q, Chen H, Chen J: PEG-PLA nanoparticles modified wi
th APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy. Biomaterials 2014, 35(28):8215-8226.
16.Hatzis C, Bedard PL, Birkbak NJ, Beck AH, Aerts HJ, Stem DF, Shi L, Clarke R, Quackenbush J, Haibe-Kains B: Enhancing
reproducibility in cancer drug screening: how do we move forward?Cancer Res 2014, 74(15):4016-4023.
17.Zhang C, Zheng X, Wan X, Shao X, Liu Q, Zhang Z, Zhang Q: The potential use of H102 peptide-loaded dual-functi
onal nanoparticles in the treatment of Alzheimer's disease. J Control Release 2014, 192:317-324.
18.Li Y, Zeng X, Wang S, Sun Y, Wang Z, Fan J, Song P, Ju D: Inhibition of autophagy protects against PAMAM dendr
imers-induced hepatotoxicity. Nanotoxicology 2015, 9(3):344-355.
19.A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequenc
ing Quality Control Consortium. Nat Biotechnol 2014, 32(9):903-914.
20.Gao X, Li C: Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier. Small 2014, 10(3):426-440.
21.Han L, Guo Y, Ma H, He X, Kuang Y, Zhang N, Lim E, Zhou W, Jiang C: Acid active receptor-specific peptide ligand for
in vivo tumor-targeted delivery. Small 2013, 9(21):3647-3658.
22.Ye L, Fan J, Shi X, Tao Q, Ye D, Xian Z, Zeng X, Li Y, Feng M, Ju D: Tumor necrosis therapy antibody interleukin-2 fu
sion protein elicits prolonged and targeted antitumor effects in vivo.
Appl Microbiol Biotechnol 2014, 98(9):4053-4061.
23.Gao H, Yang Z, Zhang S, Pang Z, Liu Q, Jiang X: Study and evaluation of mechanisms of dual targeting drug deliver
y system with tumor microenvironment assays compared with normal assays. Acta Biomater 2014, 10(2):858-867.
24.Cao Z, Wang P, Qiu X, Lau C, Lu J: Ligation-triggered fluorescent silver nanoclusters system for the detection of
nicotinamide adenine dinucleotide. Anal Bioanal Chem 2014, 406(7):1895-1902.
25.Cai S, Cao Z, Lau C, Lu J: Label-free technology for the amplified detection of microRNA based on the allosteric
hairpin DNA switch and hybridization chain reaction. Analyst 2014, 139(22):6022-6027.
26.Ge H, Bao H, Zhang L, Chen G: Immobilization of trypsin on miniature incandescent bulbs for infrared-assisted pro
teolysis. Anal Chim Acta 2014, 845:77-84.
27.Wang Z, Shi X, Li Y, Zeng X, Fan J, Sun Y, Xian Z, Zhang G, Wang S, Hu H et al: Involvement of autophagy in recombin
ant human arginase-induced cell apoptosis and growth inhibition of malignant melanoma cells.
Appl Microbiol Biotechnol 2014, 98(6):2485-2494.
28.Fan J, Dong X, Zhang W, Zeng X, Li Y, Sun Y, Wang S, Wang Z, Gao H, Zhao W et al: Tyrosine kinase inhibitor Thiotanib
targets Bcr-Abl and induces apoptosis and autophagy in human chronic myeloid leukemia cells.
Appl Microbiol Biotechnol 2014, 98(23):9763-9775.
29.Liu H, Zhao D, Chang J, Yan L, Zhao F, Wu Y, Xu T, Gong T, Chen L, He N et al: Efficacy of novel antibacterial compoun
ds targeting histidine kinase YycG protein. Appl Microbiol Biotechnol 2014, 98(13):6003-6013.
30.Wang J, Lei Y, Xie C, Lu W, Wagner E, Xie Z, Gao J, Zhang X, Yan Z, Liu M: Retro-inverso CendR peptide-mediated po
lyethyleneimine for intracranial glioblastoma-targeting gene therapy. Bioconjug Chem 2014, 25(2):414-423.
31.Qiu X, Wang P, Cao Z: Hybridization chain reaction modulated DNA-hosted silver nanoclusters for fluorescent
identification of single nucleotide polymorphisms in the let-7 miRNA family. Biosens Bioelectron 2014, 60:351-357.
32.Shi X, Zhou W, Huang H, Zhu H, Zhou P, Ju D: Inhibition of the inflammatory cytokine tumor necrosis factor-alpha
with etanercept provides protection against lethal H1N1 influenza infection in mice. Crit Care 2013, 17(6):R301.
33.Zhang X, Wu W: Ligand-mediated active targeting for enhanced oral absorption.
Drug Discov Today 2014, 19(7):898-904.
34.Qian ZM, Ke Y: Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer's Disease?
Front Aging Neurosci 2014, 6:216.
35.Gao H, Zhang S, Yang Z, Cao S, Jiang X, Pang Z: In vitro and in vivo intracellular distribution and anti-glioblastoma
effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide. Int J Pharm 2014, 466(1-2):8-17.
36.Wang B, Feng D, Han L, Fan J, Zhang X, Wang X, Ye L, Shi X, Feng M: Combination of apolipoprotein A1-modi liposom
e-doxorubicin with autophagy inhibitors overcame drug resistance in vitro. J Pharm Sci 2014, 103(12):3994-4004.
37.Xu G, Lv B, Roberge JY, Xu B, Du J, Dong J, Chen Y, Peng K, Zhang L, Tang X et al: Design, synthesis, and biological eva
luation of deuterated C-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransp
orter 2 inhibitor for the treatment of type 2 diabetes. J Med Chem 2014, 57(4):1236-1251.
38.Feng M, Liao Z, Han L, Li J, Ye L: Enhancement of microbial hydroxylation of 13-ethyl-gon-4-ene-3,17-dione by M
etarhizium anisopliae using nano-liposome technique. J Ind Microbiol Biotechnol 2014, 41(4):619-627.
39.Huang G, Zhang C, Long Y, Wynn J, Liu Y, Wang W, Gao J: Low temperature preparation of alpha-FeOOH/reduced gr
aphene oxide and its catalytic activity for the photodegradation of an organic dye.
Nanotechnology 2013, 24(39):395601.
40.Liu MM, Chen XY, Huang YQ, Feng P, Guo YL, Yang G, Chen Y: Hybrids of phenylsulfonylfuroxan and coumarin as pote
nt antitumor agents. J Med Chem 2014, 57(22):9343-9356.
41.Zhan X, Wang J, Liu Y, Peng Y, Tan W: GPCR-like signaling mediated by smoothened contributes to acquired chemo
resistance through activating Gli. Mol Cancer 2014, 13:4.
42.Liu Y, He X, Kuang Y, An S, Wang C, Guo Y, Ma H, Lou J, Jiang C: A bacteria deriving peptide modified dendrigraft poly
-l-lysines (DGL) self-assembling nanoplatform for targeted gene delivery. Mol Pharm 2014, 11(10):3330-3341.
43.Wei X, Zhan C, Chen X, Hou J, Xie C, Lu W: Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires
brain-targeted drug delivery. Mol Pharm 2014, 11(10):3261-3268.
44.Miao D, Jiang M, Liu Z, Gu G, Hu Q, Kang T, Song Q, Yao L, Li W, Gao X et al: Co-administration of dual-targeting nanop
articles with penetration enhancement peptide for antiglioblastoma therapy. Mol Pharm 2014, 11(1):90-101.
45.Qian ZM, He X, Liang T, Wu KC, Yan YC, Lu LN, Yang G, Luo QQ, Yung WH, Ke Y: Lipopolysaccharides upregulate hepci
din in neuron via microglia and the IL-6/STAT3 signaling pathway. Mol Neurobiol 2014, 50(3):811-820.
46.Du F, Qian ZM, Luo Q, Yung WH, Ke Y: Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Trans
port Proteins in Iron-Overloaded Rats. Mol Neurobiol 2015, 52(1):101-114.
47.Gao H, Zhang S, Cao S, Yang Z, Pang Z, Jiang X: Angiopep-2 and activatable cell-penetrating peptide dual-function
alized nanoparticles for systemic glioma-targeting delivery. Mol Pharm 2014, 11(8):2755-2763.
48.Liu C, Tai L, Zhang W, Wei G, Pan W, Lu W: Penetratin, a potentially powerful absorption enhancer for noninvasive
intraocular drug delivery. Mol Pharm 2014, 11(4):1218-1227.
49.Gao H, Xiong Y, Zhang S, Yang Z, Cao S, Jiang X: RGD and interleukin-13 peptide functionalized nanoparticles for enh
anced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
Mol Pharm 2014, 11(3):1042-1052.
50.Zhang X, Qi J, Lu Y, He W, Li X, Wu W: Biotinylated liposomes as potential carriers for the oral delivery of insulin.
Nanomedicine 2014, 10(1):167-176.
51.Zhang X, Qi J, Lu Y, Hu X, He W, Wu W: Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin:
effect of formulation variables, intracellular trafficking, and cytotoxicity. Nanoscale Res Lett 2014, 9(1):185.
52.Yu Y, Jiang X, Gong S, Feng L, Zhong Y, Pang Z: The proton permeability of self-assembled polymersomes and their
neuroprotection by enhancing a neuroprotective peptide across the blood-brain barrier after modification with
lactoferrin. Nanoscale 2014, 6(6):3250-3258.
53.Li Y, Wang S, Wang Z, Qian X, Fan J, Zeng X, Sun Y, Song P, Feng M, Ju D: Cationic poly(amidoamine) dendrimers induc
ed cyto-protective autophagy in hepatocellular carcinoma cells. Nanotechnology 2014, 25(36):365101.
54.Zhang W, Wang Y, Lee BT, Liu C, Wei G, Lu W: A novel nanoscale-dispersed eye ointment for the treatment of dry
eye disease. Nanotechnology 2014, 25(12):125101.
55.Huang XT, Qian ZM, He X, Gong Q, Wu KC, Jiang LR, Lu LN, Zhu ZJ, Zhang HY, Yung WH et al: Reducing iron in the brain:
a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
Neurobiol Aging 2014, 35(5):1045-1054.
56.Wei J, Chen J, Liang X, Guo X: Microwave-assisted extraction in combination with HPLC-UV for quantitative analys
is of six bioactive oxoisoaporphine alkaloids in Menispermum dauricum DC. Biomed Chromatogr 2015.
57.Liu Q, Zhang C, Zheng X, Shao X, Zhang X, Zhang Q, Jiang X: Preparation and evaluation of antigen/N-trimethylamino
ethylmethacrylate chitosan conjugates for nasal immunization. Vaccine 2014, 32(22):2582-2590.
58.Li D, Wang Y, Lau C, Lu J: xMAP array microspheres based stem-loop structured probes as conformational switches
for multiplexing detection of miRNAs. Anal Chem 2014, 86(20):10148-10156.
